SYK Logo

Stryker Corporation (SYK) 

NYSE
Market Cap
$148.6B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
387 of 774
Rank in Industry
51 of 99

Largest Insider Buys in Sector

SYK Stock Price History Chart

SYK Stock Performance

About Stryker Corporation

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and …

Insider Activity of Stryker Corporation

Over the last 12 months, insiders at Stryker Corporation have bought $0 and sold $289.41M worth of Stryker Corporation stock.

On average, over the past 5 years, insiders at Stryker Corporation have bought $29,617 and sold $135.03M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 53 shares for transaction amount of $10,173 was made by Doliveux Roch (director) on 2020‑07‑31.

List of Insider Buy and Sell Transactions, Stryker Corporation

2024-11-15SaleGroup President
514
0.0001%
$391.16$201,056-1.13%
2024-11-07SaleChair and CEO
57,313
0.015%
$368.70$21.13M+4.48%
2024-11-05Sale
230,000
0.0604%
$367.37$84.49M+0.11%
2024-09-17SaleVP, Chief HR Officer
7,347
0.0019%
$366.98$2.7M-0.72%
2024-09-13SaleVP, Chief HR Officer
2,121
0.0006%
$370.00$784,770-2.12%
2024-08-27SaleGroup President
600
0.0002%
$355.00$213,000+0.78%
2024-08-06Sale
190,000
0.05%
$323.46$61.46M+11.48%
2024-08-02SaleVP, Chief Financial Officer
20,000
0.0053%
$333.00$6.66M+8.48%
2024-05-22SaleVP, Chief Legal Officer
2,007
0.0005%
$332.99$668,308+4.80%
2024-05-15SaleVP, Chief Financial Officer
10,000
0.0026%
$327.65$3.28M+5.65%
2024-03-07SaleVP, Chief Accounting Officer
7,690
0.002%
$358.48$2.76M-2.41%
2024-02-09SaleVP, Chief Financial Officer
9,600
0.0027%
$342.81$3.29M+2.18%
2024-02-06Sale
92,296
0.026%
$339.95$31.38M+2.81%
2024-02-05Sale
201,146
0.0573%
$342.90$68.97M+1.87%
2024-02-02Saledirector
3,273
0.0009%
$341.00$1.12M+2.12%
2023-12-01Saledirector
500
0.0001%
$298.22$149,112+15.27%
2023-11-28SaleVP, Chief Accounting Officer
573
0.0002%
$292.28$167,477+17.18%
2023-11-17SaleChair and CEO
56,483
0.0149%
$287.91$16.26M+18.74%
2023-11-16Saledirector
500
0.0001%
$291.92$145,962+16.79%
2023-11-15Saledirector
500
0.0001%
$287.50$143,751+20.30%

Insider Historical Profitability

9.54%
Doliveux Rochdirector
22070
0.0058%
$389.81161+9.54%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$11.26B8.2631.46M+0.99%+$110.79M0.21
BlackRock$9.39B6.8926.24M+5.29%+$472.22M0.21
State Street$5.15B3.7714.35M+0.61%+$31.11M0.21
T. Rowe Price$4.25B3.1211.88M-5.28%-$236.89M0.52
Wellington Management Company$3.88B2.8510.84M-10.9%-$474.66M0.66
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.